BDNF and depressive symptom measurement: These results suggest that the difference in pro-BDNF levels that we observed previously between abstainers and nonabstainers might not be predictive of the maintenance of abstinence but rather of the proportion of individuals with depressive episodes at M2 in the two samples, as pro-BDNF levels increase during depression [26,50].